Literature DB >> 6771090

Levonorgestrel plasma concentrations and hormone profiles after insertion and after one year of treatment with a levonorgestrel-IUD.

C G Nilsson, P Lähteenmäki, T Luukkainen.   

Abstract

Plasma concentrations of levonorgestrel, progesterone, estradiol, FSH and LH were measured in seven volunteers who had a levonorgestrel-releasing IUD inserted postmenstrually. Blood samples were collected twice weekly during a mean of 93 days immediately postmenstrually and during a mean of 41 days over the twelfth to fifteenth month of treatment. Patterns of bleeding were studied during the first year of treatment. The IUDs used were designed to release 25 micrograms/day of levonorgestrel. The mean +/- SD plasma concentration of levonorgestrel for all subjects during the first three months was 260 +/- 68 pg/ml, and 129 +/- 28 pg/ml after one year of treatment. During the initial period of blood sampling only two of the subjects ovulated, while only two did not ovulate after one year of treatment. Intermenstrual spotting occurred during the first sixty days of treatment. Three subjects developed amenorrhea at the end of the first year. All the subjects continued the use of the IUD and no pregnancies occurred.

Entities:  

Keywords:  Biology; Clinical Research; Contraception; Contraceptive Agents, Female--analysis; Contraceptive Agents, Progestin--analysis; Contraceptive Agents--analysis; Contraceptive Effectiveness; Contraceptive Methods; Endocrine System; Estradiol--analysis; Estrogens; Family Planning; Follicle Stimulating Hormone--analysis; Gonadotropins; Gonadotropins, Pituitary; Hormones; Human Volunteers; Iud; Iud, Hormone Releasing; Levonorgestrel--analysis; Luteinizing Hormone--analysis; Menstrual Cycle; Menstruation; Physiology; Postmenstruation; Progestational Hormones; Progesterone--analysis; Reproduction; Research Methodology; Use-effectiveness

Mesh:

Substances:

Year:  1980        PMID: 6771090     DOI: 10.1016/0010-7824(80)90003-7

Source DB:  PubMed          Journal:  Contraception        ISSN: 0010-7824            Impact factor:   3.375


  9 in total

Review 1.  A risk-benefit assessment of the levonorgestrel-releasing intrauterine system.

Authors:  F Sturridge; J Guillebaud
Journal:  Drug Saf       Date:  1996-12       Impact factor: 5.606

2.  Effect of domestically-made levonorgestrel-releasing intrauterine device on the endocrine system and menstruation in monkeys.

Authors:  C Wu; W Xia; X Wu; R Li; X Huang; Y Yan; D Huang
Journal:  J Tongji Med Univ       Date:  1996

3.  Drug release testing of long-acting intrauterine systems.

Authors:  Quanying Bao; Yuan Zou; Yan Wang; Darby Kozak; Stephanie Choi; Diane J Burgess
Journal:  J Control Release       Date:  2019-11-13       Impact factor: 9.776

4.  Levonorgestrel levels in serum and uterine flushings in women bearing LNG-Cu-IUD.

Authors:  J P Shi; X R Wu
Journal:  J Tongji Med Univ       Date:  1993

5.  An intravaginal ring that releases three antiviral agents and a contraceptive blocks SHIV-RT infection, reduces HSV-2 shedding, and suppresses hormonal cycling in rhesus macaques.

Authors:  Nina Derby; Meropi Aravantinou; Jessica Kenney; Shweta R Ugaonkar; Asa Wesenberg; Jolanta Wilk; Larisa Kizima; Aixa Rodriguez; Shimin Zhang; Olga Mizenina; Keith Levendosky; Michael L Cooney; Samantha Seidor; Agegnehu Gettie; Brooke Grasperge; James Blanchard; Michael Piatak; Jeffrey D Lifson; José Fernández-Romero; Thomas M Zydowsky; Melissa Robbiani
Journal:  Drug Deliv Transl Res       Date:  2017-12       Impact factor: 4.617

Review 6.  The Double Engines and Single Checkpoint Theory of Endometriosis.

Authors:  Che-Fang Hsu; Aye Aye Khine; Hsuan-Shun Huang; Tang-Yuan Chu
Journal:  Biomedicines       Date:  2022-06-14

7.  Review of the safety, efficacy and patient acceptability of the levonorgestrel-releasing intrauterine system.

Authors:  Chandra Kailasam; David Cahill
Journal:  Patient Prefer Adherence       Date:  2008-02-02       Impact factor: 2.711

8.  A Novel Microbicide/Contraceptive Intravaginal Ring Protects Macaque Genital Mucosa against SHIV-RT Infection Ex Vivo.

Authors:  Guillermo Villegas; Giulia Calenda; Shweta Ugaonkar; Shimin Zhang; Larisa Kizima; Olga Mizenina; Agegnehu Gettie; James Blanchard; Michael L Cooney; Melissa Robbiani; José A Fernández-Romero; Thomas M Zydowsky; Natalia Teleshova
Journal:  PLoS One       Date:  2016-07-18       Impact factor: 3.240

9.  Progesterone receptor ligands for the treatment of endometriosis: the mechanisms behind therapeutic success and failure.

Authors:  Fernando M Reis; Larissa M Coutinho; Silvia Vannuccini; Frédéric Batteux; Charles Chapron; Felice Petraglia
Journal:  Hum Reprod Update       Date:  2020-06-18       Impact factor: 15.610

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.